8-K - VolitionRx Limited | StockGist

Current Report Details

Event Type

Material Agreement

Securities Issuance

Exhibits On

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 7, 2026, VolitionRx Limited (the “Company”) entered into an amended and restated securities purchase agre

Material Agreement

$2.0M$2.4M$70.0K$7.5M

Source Document

3.02

in its entirety. Based in part upon the representations of Lind in the Amended SPA, the offering and sale of the securities described above was made in reliance

Securities Issuance

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 4.1 Form of Lind Warrant 10.1 Amended and Restated Securities Purchase Agreement, da

Exhibits Only

Source Document

Exhibits (5)

10.1

AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT

10.2

FORM OF SENIOR SECURED CONVERTIBLE PROMISSORY NOTE

4.1

FORM OF LIND WARRANT

8-K

FORM 8-K

99.1

PRESS RELEASE